Download PDF
CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2015; 25(04): 365-367
DOI: 10.4103/0971-3026.169460
Vascular and Interventional Radiology

Use of a vascular sheath for introduction of radiofrequency ablation probe during radiofrequency ablation of osteoid osteoma

Munawwar Ahmed
Department of Radiology, Paediatrics Orhtopaedics Unit, Christian Medical College, Vellore, Tamil Nadu, India
,
Shyamkumar N Keshava
Department of Radiology, Paediatrics Orhtopaedics Unit, Christian Medical College, Vellore, Tamil Nadu, India
,
Vinu Moses
Department of Radiology, Paediatrics Orhtopaedics Unit, Christian Medical College, Vellore, Tamil Nadu, India
,
Suraj Mammen
Department of Radiology, Paediatrics Orhtopaedics Unit, Christian Medical College, Vellore, Tamil Nadu, India
,
Korula Mani Jacob
Department of Orhtopaedics, Paediatrics Orhtopaedics Unit, Christian Medical College, Vellore, Tamil Nadu, India
,
Vrisha Madhuri
Department of Orhtopaedics, Paediatrics Orhtopaedics Unit, Christian Medical College, Vellore, Tamil Nadu, India
› Author Affiliations Financial support and sponsorship Nil.
› Further Information
  PDF Download Permissions and Reprints

Abstract

Radiofrequency ablation (RFA) has now become a preferred treatment option for osteoid osteoma. Accurate placement of RFA probe into the nidus of osteoid osteoma is important for good clinical outcome. Various methods and techniques have been described in the literature available. We describe the technique of using a vascular access sheath for introduction of RFA probe after bone drilling, which prevents loss of access to drill track and also serves as a pathway for accurate placement of RFA probe, thereby reducing the risk of damage to the RFA probe tip itself and the surrounding soft tissue.

Keywords

Computed tomography scan - osteoid osteoma - radiofrequency ablation


Publication History

Article published online:
30 July 2021

© 2015. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Motamedi D, Learch TJ, Ishimitsu DN, Motamedi K, Katz MD, Brien EW, et al. Thermal ablation of osteoid osteoma: Overview and step by-step guide. Radiographics 2009;29:2127-41.
  • 2 Busser WM, Hoogeveen YL, Veth RP, Schreuder HW, Balguid A, Renema WK, et al. Percutaneous radiofrequency ablation of osteoid osteomas with use of real-time needle guidance for accurate needle placement: A pilot study. Cardiovasc Intervent Radiol 2011;34:180-3.
  • 3 Mylona S, Patsoura S, Galani P, Karapostolakis G, Pomoni A, Thanos L. Osteoid osteomas in common and in technically challenging locations treated with computed tomography-guided percutaneous radiofrequency ablation. Skeletal Radiol 2010;39:443-9.
  • 4 Mahnken AH, Bruners P, Delbrück H, Günther RW. Radiofrequency ablation of osteoid osteoma: Initial experience with a new monopolar ablation device. Cardiovasc Intervent Radiol 2011:34;579-84.
  • 5 Mahnken AH, Tacke JA, Wildberger JE, Günther RW. Radiofrequency ablation of osteoid osteoma: Initial results with a bipolar ablation device. J Vasc Interv Radiol 2006;17:1465-70.
  • 6 Pinto CH, Taminiau AH, Vanderschueren GM, Hogendoorn PC, Bloem JL, Obermann WR. Technical considerations in CT-guided radiofrequency thermal ablation of osteoid osteoma: Tricks of the trade. AJR Am J Roentgenol 2002;179:1633-42.
  • 7 Donkol RH, Al-Nammi A, Moghazi K. Efficacy of percutaneous radiofrequency ablation of osteoid osteoma in children. Pediatr Radiol 2008;38:180-5.
  • 8 Cantwell CP, Obyrne J, Eustace S. Current trends in treatment of osteoid osteoma with an emphasis on radiofrequency ablation. Eur Radiol 2004;14:607-17.